MARKET

ZGNX

ZGNX

Zogenix
NASDAQ

Real-time Quotes | Nasdaq Last Sale

42.52
-0.07
-0.16%
Opening 12:10 10/21 EDT
OPEN
43.27
PREV CLOSE
42.59
HIGH
43.74
LOW
42.36
VOLUME
60.32K
TURNOVER
--
52 WEEK HIGH
56.50
52 WEEK LOW
33.43
MARKET CAP
1.88B
P/E (TTM)
-12.7573
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ZGNX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 12 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ZGNX News

  • Is Zogenix, Inc. (ZGNX) A Good Stock To Buy?
  • Insider Monkey.1h ago
  • Zogenix Announces Presentation of New Data for FINTEPLA® for the Treatment of Dravet Syndrome at the Child Neurology Society Annual Meeting
  • GlobeNewswire.3h ago
  • Needham Initiates Coverage On Zogenix with Buy Rating, Announces $58 Price Target
  • Benzinga.3h ago
  • Does The Zogenix, Inc. (NASDAQ:ZGNX) Share Price Fall With The Market?
  • Simply Wall St..10/11 18:33

More

Industry

Biotechnology & Medical Research
+1.07%
Pharmaceuticals & Medical Research
+0.07%

Hot Stocks

Name
Price
%Change

About ZGNX

Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders. Its primary area of therapeutic focus is epilepsy and related seizure disorders. Its lead product candidate, ZX008, is a low-dose fenfluramine for the treatment of seizures associated with Dravet syndrome. ZX008 has received orphan drug designation in the United States and European Union (EU), for the treatment of Dravet syndrome. The Company has an additional product candidate, Relday (risperidone once-monthly long-acting injectable) for the treatment of schizophrenia. Relday is a long-acting injectable formulation of risperidone. Risperidone is used to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers 13 years of age and older. It has completed the Phase I program for Relday.
More

Webull offers Zogenix, Inc. (ZGNX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.